What’s New

Latest News

News
Tinengotinib Demonstrates Strong Antitumor Activity in FGFR-Altered Cholangiocarcinoma
02/04/2026
Stephanie Holland
Results from a phase 2 trial show that tinengotinib demonstrates strong antitumor activity in patients with advanced cholangiocarcinoma who developed resistance to prior FGFR inhibitor therapy.
Results from a phase 2 trial show that tinengotinib demonstrates strong antitumor activity in patients with advanced cholangiocarcinoma who developed resistance to prior FGFR inhibitor therapy.
Results from a phase 2 trial...
02/04/2026
Oncology
Oncology
News
NCCN Adds Trodelvy as Preferred First-Line Option in Metastatic Triple-Negative Breast Cancer
02/04/2026
Grace Taylor, MS, MA
Updated National Comprehensive Cancer Network Guidelines position Trodelvy (sacituzumab govitecan-hziy) as a preferred first-line therapy in metastatic triple-negative breast cancer (TNBC).
Updated National Comprehensive Cancer Network Guidelines position Trodelvy (sacituzumab govitecan-hziy) as a preferred first-line therapy in metastatic triple-negative breast cancer (TNBC).
Updated National Comprehensive...
02/04/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
News
New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia
02/04/2026
Adagio Medical Holdings Press Release  LAGUNA HILLS, Calif. --  Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac...
Adagio Medical Holdings Press Release  LAGUNA HILLS, Calif. --  Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac...
Adagio Medical Holdings Press...
02/04/2026
EP Lab Digest
EP Lab Digest
Pulmonary Embolism
Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial
02/04/2026
The SPIRARE II pivotal clinical trial is evaluating the Vertex™ Pulmonary Embolectomy System in patients with acute, intermediate-risk pulmonary embolism (PE).
The SPIRARE II pivotal clinical trial is evaluating the Vertex™ Pulmonary Embolectomy System in patients with acute, intermediate-risk pulmonary embolism (PE).
The SPIRARE II pivotal clinical...
02/04/2026
Cath Lab Digest
Cath Lab Digest
News
EHR-Based Machine Learning Predicts Alzheimer Risk Years Before Diagnosis in US Veterans
02/04/2026
Hannah Musick
A large Veterans Health Administration study found that machine learning models analyzing Alzheimer-related keywords in routine clinical notes may predict future diagnosis up to 10 years in advance, outperforming models based on structured...
A large Veterans Health Administration study found that machine learning models analyzing Alzheimer-related keywords in routine clinical notes may predict future diagnosis up to 10 years in advance, outperforming models based on structured...
A large Veterans Health...
02/04/2026
Veterans Health Today
Veterans Health Today
Research Highlights
Gout Flares Spike After Stopping Anti-Inflammatory Prophylaxis
02/04/2026
Rebecca Mashaw
Clinicians should anticipate an important clinical risk period immediately after ceasing prophylaxis in patients with gout and integrate flare management strategies to optimize outcomes.
Clinicians should anticipate an important clinical risk period immediately after ceasing prophylaxis in patients with gout and integrate flare management strategies to optimize outcomes.
Clinicians should anticipate an...
02/04/2026
Rheumatology & Arthritis
Rheumatology & Arthritis
News
RAMPART Appoints Former Thoratec CEO Gary Burbach as Chairman of the Board
02/04/2026
BIRMINGHAM, Ala. — February 4, 2026 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional radiation safety, today announced the appointment of Gerhard (Gary) F. Burbach as Chairman of its Board of...
BIRMINGHAM, Ala. — February 4, 2026 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional radiation safety, today announced the appointment of Gerhard (Gary) F. Burbach as Chairman of its Board of...
BIRMINGHAM, Ala. — February 4,...
02/04/2026
Vascular Disease Management
Vascular Disease Management

Latest Research

jan/feb issue
The Dermatologist
Forward Focus: Top Trends in Dermatology for 2026
Vol. 34, Issue 1, Issue February 2026
CLD 2026 Jan Feb cover..png
Cath Lab Digest
Impact of TAVR on Functional vs. Degenerative Mitral Regurgitation
Vol. 34, Issue 1, Issue February 2026

HMP Global Learning Network

Featured Interviews

Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
02/01/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
02/01/2026
Vascular Disease Management
tourniquet stop the bleed DeBoer
Videos
Pediatric Video Tutorial: Stop the Bleed Part 2—Tourniquet Tips
01/30/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets,...
01/30/2026
EMSWorld
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Conference Coverage
Clinical Strategies for the Assessment and Management of Antibody-Drug Conjugate Toxicities
01/30/2026
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C,...
01/30/2026
Oncology Learning Network APP Institute
CTP News Desk hero image
Viewpoints
Avoiding Audits and Making Sure You Get Paid
01/30/2026
Caroline E. Fife, MD, FAAFP, CWS, FUHM
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits,...
01/30/2026
Wounds
Alison Schram, MD, Memorial Sloan Kettering Cancer Center
Videos
Treating NRG1 Fusion-Positive Non-Small Cell Lung Cancer
01/02/2026
Alison Schram, MD
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the...
01/02/2026
Oncology
Matthew Regulski, DPM, FFPM, RCPS (Glasgow), DABMSP
Viewpoints
Cutting Costs, Raising Standards: The Case for Evidence-Based CTP Use
12/30/2025
Matthew J. Regulski, DPM, ABMSP, CMET, FAPWH(c)
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are...
12/30/2025
Wounds
Michael Kappelman
From the AIBD Open Air Studio
The Sherman Prize: Michael Kappelman, MD
12/29/2025
Michael Kappelman, MD
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the...
12/29/2025
Advances in Inflammatory Bowel Disease Network
CTP News Desk Image
Viewpoints
Observations on Potential Pivots and Continued Change
12/01/2025
Scott Nelson
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on...
12/01/2025
Wounds
Corey Siegel
Conference Coverage
Corey Siegel, MD, on Improving IBD Care Models
11/28/2025
Corey A. Siegel, MD, MS
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke...
11/28/2025
Advances in Inflammatory Bowel Disease Network
BDHC thumbnail
Videos
Breaking Down Cancer Prevention: What Really Works?
11/26/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down...
11/26/2025
Cancer Care Business Exchange

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use